NCT02136940View on ClinicalTrials.gov

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
GlaucomaOcular HypertensionEye Disease
Interventions
DRUG

AMA0076

DRUG

Placebo

Trial Locations (9)

Unknown

Artesia Clinical - Site 11, Artesia

Inglewood Clinical Site - Site 15, Inglewood

Petaluma Clinical Site - Site 17, Petaluma

Morrow Clinical Site - Site13, Morrow

Roswell Clinical Site - Site 18, Roswell

Rochester Clinical Site - Site 12, Rochester

Slingerlands Clinical Site - Site 19, Slingerlands

Charlotte Clinical Site - Site 14, Charlotte

High Point Clinical Site - Site 16, High Point

Sponsors

Lead Sponsor

Amakem, NV
All Listed Sponsors
lead

Amakem, NV

INDUSTRY

NCT02136940 - Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter